Co-Founder & CEO
JJ Kang, Ph.D., is co-founder and CEO of Appia Bio. Prior to starting Appia Bio, JJ was a partner on the investment team at The Column Group, a life sciences venture capital firm. She led investments to launch portfolio companies Tenaya Therapeutics, Exonics Therapeutics and Escient Pharmaceuticals and served on their boards. Prior to that, she worked at FibroGen in project management and corporate strategy. JJ earned her Ph.D. in chemical biology at Caltech and her B.A. in chemistry from Harvard University.